Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro.

Yasuda, H; Shima, N; Nakagawa, N; Mochizuki, S I; Yano, K; Fujise, N; Sato, Y; Goto, M; Yamaguchi, K; Kuriyama, M; Kanno, T; Murakami, A; Tsuda, E; Morinaga, T; Higashio, K

Yasuda, H; Shima, N; Nakagawa, N; Mochizuki, S I; Yano, K; Fujise, N; Sato, Y; Goto, M; Yamaguchi, K; Kuriyama, M; Kanno, T; Murakami, A; Tsuda, E; Morinaga, T; Higashio, K.

Affiliation

Yasuda H; Research Institute of Life Science, Snow Brand Milk Products Co., Ltd., Tochigi, Japan. fvbd7042@mb.infoweb.or.jp

Endocrinology ; 139(3): 1329-37, 1998 Mar.

Article in En | MEDLINE | ID: mdl-9492069

Subject(s)

Glycoproteins/physiology; Osteoclasts/physiology; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor/physiology; Amino Acid Sequence; Animals; Bone Density/drug effects; Bone Remodeling; Cells, Cultured; Cloning, Molecular; Glycoproteins/genetics; Humans; Male; Mice; Molecular Sequence Data; Osteoclasts/drug effects; Osteoprotegerin; Rats; Rats, Sprague-Dawley; Receptors, Tumor Necrosis Factor/genetics; Recombinant Proteins/pharmacology

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Osteoclasts / Glycoproteins / Receptors, Tumor Necrosis Factor / Receptors, Cytoplasmic and Nuclear Limits: Animals / Humans / Male Language: En Year: 1998 Type: Article

Search on Google

XML

PubMed Links